|
|
I Maruyama, H H Salem, P W Majerus
J Clin Invest. 1984;
74(1):224
doi:10.1172/JCI111405
Abstract |
Full text
| PDF

I
n vitro the rate of protein C activation by thrombin is significantly accelerated by two distinct cofactors (a) the endothelial cell surface protein, thrombomodulin, and (b) human coagulation Factor Va. We have recently reported that the activity of Factor Va is contained in the 78,000-D light chain. In this study we have investigated the effects of Factor Va and its light chain on the activation of protein C in the presence of cultured endothelial cells. Thrombin-catalyzed protein C activation on human umbilical vein endothelial cells was enhanced by Factor Va. The ability of Factor Va to stimulate protein C activation on these cells was saturated at 50 nM Factor Va and was observed at several protein C concentrations. Isolated Factor Va light chain in concentrations up to 50 nM also accelerated protein C activation on endothelial cells, but higher concentrations inhibited the reaction. The effects of Factor Va or its light chain on protein C activation were also shown on a mouse hemangioma cell line but not on human fibroblasts nor on a human amelanotic melanoma cell line. Protein C activation on endothelial cells was partially inhibited by a goat anti-thrombomodulin antibody and further addition of a polyclonal rabbit anti-Factor V(Va) antibody resulted in additional inhibition. Endothelial cells grown in medium supplemented with human serum, devoid of Factor V coagulant activity, contained cell surface Factor V(Va) (approximately 15,000 molecules/cell) as measured by the binding of a monoclonal IgG directed against Factor V(Va). These cells also bound an additional 6,000-10,000 molecules Factor Va per cell as determined by direct binding studies using 125I-Factor Va. We suggest that thrombomodulin and Factor Va act in concert to regulate protein C activation on the surface of endothelial cells.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(16)
| Title and authors |
Publication |
Year |
My research history in human thrombomodulin
Ikuro MARUYAMA
|
Jpn J Thromb Hemost
|
2010 |
Increased P-Selectin Expression on Platelets and Decreased Plasma Thrombomodulin in Fontan Patients
Hidemi Kajimoto, Makoto Nakazawa, Kagari Murasaki, Nobuhisa Hagiwara, Toshio Nakanishi
|
Circ J
|
2009 |
Recombinant human soluble thrombomodulin decreases the plasma high-mobility group box-1 protein levels, whereas improving the acute liver injury and survival rates in experimental endotoxemia
Masaru Nagato, Kohji Okamoto, Yukio Abe, Aiichiro Higure, Koji Yamaguchi
|
Critical Care Medicine
|
2009 |
Increased Thrombogenesity in Patients With Cyanotic Congenital Heart Disease
Hidemi Kajimoto, Makoto Nakazawa, Kagari Murasaki, Yoshiki Mori, Kenjiro Tanoue, Hiroshi Kasanuki, Toshio Nakanishi
|
Circ J
|
2007 |
The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism
Kazuhiro Abeyama, David M. Stern, Yuji Ito, Ko-ichi Kawahara, Yasushi Yoshimoto, Motoyuki Tanaka, Tomonori Uchimura, Nobuo Ida, Yoshiaki Yamazaki, Shingo Yamada, Yasuhiko Yamamoto, Hiroshi Yamamoto, Satoshi Iino, Noboru Taniguchi, Ikuro Maruyama
|
J. Clin. Invest.
|
2005 |
Thrombomodulin expression on Langerhans' islet: can endogenous 'anticoagulant on demand' overcome detrimental thrombotic complications in clinical islet transplantation?
S. Iino, K. Abeyama, K.-I. Kawahara, T. Aikou, I. Maruyama
|
Journal of Thrombosis and Haemostasis
|
2004 |
A subcloned human esophageal squamous cell carcinoma cell line with low thrombomodulin expression showed increased invasiveness compared with a high thrombomodulin-expressing clone – thrombomodulin as a possible candidate for an adhesion molecule of squamous cell carcinoma
Yoshifumi Matsushita, Kiyotaka Yoshiie, Yoshiro Imamura, Hiroki Ogawa, Hiroshi Imamura, Sonshinn Takao, Suguru Yonezawa, Takashi Aikou, Ikuro Maruyama, Eiichi Sato
|
Cancer Letters
|
1998 |
Chronic pulmonary hypertension‐the monocrotaline model and involvement of the hemostatic system
A. E. Schultze, R. A. Roth
|
J Toxicol Environ Health Part B Crit Rev
|
1998 |
The expression of thymidine phosphorylase and thrombomodulin in human colorectal carcinomas
Yuji Takebayashi, Kazutaka Yamada, Ikuro Maruyama, Ryu-ichi Fujii, Shin-ichi Akiyama, Takashi Aikou
|
Cancer Letters
|
1995 |
Cellular and molecular regulation of factor V expression in human megakaryocytes
Alan M. Gewirtz, Charles Shapiro, Yu Min Shen, Robert Boyd, Robert W. Colman
|
J. Cell. Physiol.
|
1992 |
|